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Introduction
Glaucoma is a chronic eye disease that results in irreversible optic nerve damage, which causes severe vision loss and blindness. It is the second leading cause of blindness worldwide and one of the leading causes of irreversible blindness [1] . The estimated number of people around the world with glaucoma was 64.3 million in 2013, and this number is expected to increase to 111.8 million in 2040. The increasing trend in the number of patients with glaucoma will continue because of increased life expectancy. In recently published systematic reviews, the glaucoma prevalence in subjects >40 years of age was estimated to be 3.54% (95% confidence interval [CI]: 2.09-5.82) globally and 3.40% (95% CI: 2.26-5.02) in Asia [2] .
Most studies examining the prevalence of glaucoma have been population-based, but these may be limited in determining glaucoma prevalence in real world because of differences in setting of glaucoma diagnosis between clinical practice and population-based studies. In additional, population-based studies varied widely in terms of the eye examination methods and case definitions used [3] .
Korean National Health Insurance (NHI) covers 50 million people in South Korea, which represents approximately 97% of the Korean population. Therefore, we may be able to use this database to obtain accurate statistics on glaucoma in South Korea. These national claims database provides unique real-world data from a large, complete, and unselected population, providing important information about all types of glaucoma disease [3] .
In the current study, we estimated the prevalence of glaucoma between 2008 and 2013 in Korea using the national health claims database. This prevalence was then compared to estimates made with previous population-based studies. The direct economic burden of glaucoma in Korea from 2008 to 2013 was also investigated.
Materials and Methods
All study conduct adhered to the tenets of the Declaration of Helsinki. The Institutional Review Board of Yonsei [4] . The database contains data on diagnoses, procedures, prescriptions, demographics, and direct medical costs. The HIRA database manages claims using the sixth edition of the Korean Classification of Disease (KCD-6), which is similar to the International Classification of Disease (ICD-10) system. The diagnostic codes for glaucoma are H40 (glaucoma) and H42 (glaucoma in other diseases classified elsewhere). The H40 code family includes diagnoses of glaucoma suspect (or ocular hypertension [OHT], H400), open angle glaucoma (OAG, H401, including normal tension glaucoma [NTG] and primary open angle glaucoma [POAG]), angle closure glaucoma (ACG, H402), secondary glaucoma (H403-406), other glaucoma (H408), and unspecified glaucoma (H409). The H42 code family includes diagnoses of glaucoma related to endocrine, nutritional, and metabolic diseases (H420). Surgical codes used to identify patients with glaucoma were those for nonpenetrating filtering surgery (S5040), iridotomy (S5041), filtering surgery (S5042), trabeculectomy (S5043), cyclophotocoagulation (S5044), cyclocryosurgery for glaucoma (S4055), trabeculotomy (S4057), sinusotomy (S4058), and glaucoma implant surgery (S5049).
Data from the HIRA database were used to estimate the size of the glaucoma population in South Korea. From all payment requests between 2008 and 2013, we extracted all requests for inpatient and outpatient services for patients >40 years old whose main or secondary cause for the visit was documented with an H40 or H42 KCD diagnosis code. Patients that were given an H400 diagnosis code (glaucoma suspect or OHT) were excluded from glaucoma prevalence estimations.
For the calculation of glaucoma care cost, we applied the annual KRW-(Korean Won-) USD (US dollar) exchange rate of each year and current KRW for each year was converted to constant KRW (2013) using an annual inflation rate of 3% (average increase in consumer price index over 6-year period in South Korea). In the glaucoma care cost, all payment requests for glaucoma diagnosis code were included such as diagnostic test, procedure, and prescriptions.
The annual prevalence of glaucoma was calculated as the number of people who were diagnosed with glaucoma divided by the number of people that received NHI coverage that year. The prevalence of glaucoma was based on patients >40 years of age and was examined by age and sex. The 95% CI of the prevalence rate was estimated based on a Poisson distribution. Linear trend analyses were performed using Mantel-Haenszel tests. All statistical analyses were performed using SPSS statistical software (ver. 19.0; SPSS, Inc., Chicago, IL, USA). Statistical significance was defined as a value of <0.05.
Results
Among the general population that was at least 40 Table 1) .
The most common glaucoma subtype was OAG, which accounted for 56-62% of all glaucoma cases. The prevalence of OAG, including NTG, was 0.459% (57. Table 2) .
The prevalence of glaucoma increased with age. In 2013, the glaucoma prevalence was 2.35% in subjects >80 years old, 2.68% in subjects 70-79 years old, 1.66% in subjects 60-69 years old, 0.70% in subjects 50-59 years old, and 0.35% in subjects 40-49 years old. The prevalence of glaucoma increased annually in each age group but was significantly higher in older age groups (>60 years) than in younger ones ( Figure 1 ). After adjusting for gender, the odds ratio (OR) of developing glaucoma was 1.616-1.759 with each decade increase in age (Table 3) . Glaucoma prevalence was higher in males than in females during the time period examined (Table 2) . After adjusting for age, males were more likely to have glaucoma than females (OR: 1.131-1.300, Table 3 ).
The total number and cost of glaucoma surgeries increased annually, with 9773 glaucoma surgeries performed in 2009, 9541 surgeries performed in 2010, 10,061 surgeries performed in 2011, 10,912 surgeries performed in 2012, and Table 4 ).
Discussion
We assessed the estimated prevalence of glaucoma and the trend in glaucoma-associated figures in Korea over 6 years (2008 to 2013) using the national claims database. Advantages of using the national claims database over population surveys include its very large sample size and its more representative diagnostic patterns. Korean NHI is compulsory social insurance that covers 50 million Korean people (approximately 97% of population). It is more powerful than any other national claims database. Additionally, claims data are not regional, but nationwide, which provide more accurate Results based on data from the national claims database.
estimates of disease prevalence in Korea. Because claims data are longitudinal, they can also be used to recognize trends over time in disease prevalence.
In the present study, the number of patients with glaucoma significantly increased each year (54% increase between 2008 and 2013). Tham et al. [2] estimated that the number of people worldwide with glaucoma will increase over 2013 levels by 18.3% in 2020 and by 74% in 2040, largely because of an increased life expectancy. In our study, the proportion of elderly patients (>60 years) in the Korean NHI database gradually increased from 14.28% in 2008 to 16.88% in 2013. This was not enough to explain the marked increase we observed in the incidence of glaucoma, which was higher than in previous studies [1, 2] .
It is possible that the dramatic increase in people with glaucoma observed here does not reflect an increase in glaucoma prevalence. Rather, the glaucoma increase may reflect improvements in glaucoma detection, which may have Journal of Ophthalmology 5 Results based upon data from the national claims database. a Estimated value based on the 3.5% glaucoma prevalence reported in a systematic review [2] ) and the number of ophthalmologists increased by 23% (determined from NHI database). The increase in refractive and cataract surgery also led to improvements in glaucoma detection in Korea. In almost all eye clinics, preoperative ophthalmic examinations include fundus and optic nerve examinations. Therefore, the higher surgical rate increased the chance of identifying patients with asymptomatic glaucoma. Second, the national health education and health promotion program has increased interest and awareness about health and disease in Korea. Additionally, the development of the internet and multimedia has improved disease awareness among the general population. Informing the community about glaucoma is an important step in promoting preventive ophthalmic care [5] . In Korea, news stories related to glaucoma significantly increased from 533 stories in 2008 to 1490 stories in 2013 (data obtained from the internet portal site, NAVER [http://www.naver.com/]). Additionally, the Korean national health check-up program does not include a fundus examination, but most hospitals have implemented programs that include fundus examinations as part of medical checkups. Therefore, more fundus examinations were performed as the population received more recent medical check-ups, which subsequently resulted in more glaucoma diagnoses.
Several studies have reported the prevalence of glaucoma in East Asia and in South Korea. Kim et al. [6] found that the prevalence of glaucoma in rural populations over 50 years of age was 3.4% (95% CI: 2.1%-4.8%). The Namil Study Group performed a population-based survey of glaucoma in a rural area of central South Korea and found that the prevalence of glaucoma was 4.5% [7] . Similarly, the Tajimi Study Report [8, 9] reported a glaucoma prevalence of 5.0% (95% CI: 4.2%-5.8%) in central Japan and a systematic review reported a glaucoma prevalence of 2.26%-5.02% in Asia [2] . Although the prevalence of glaucoma among the population that visited an eye clinic was similar to other reports (2.53-2.82%), we found a much lower estimated prevalence of glaucoma among the total population (1.06%), as well as a lower POAG prevalence (0.65%), in 2013 based on the national claims database. We speculate that our glaucoma prevalence was underestimated, even though disease incidence can be overestimated when using national claims data [10, 11] .
Other population-based studies found a substantially higher prevalence of glaucoma than reported in the current study. Our study may have underestimated glaucoma prevalence for several reasons. First, the most common type of glaucoma is chronic asymptomatic disease. Because glaucoma can remain asymptomatic until it becomes severe, there is a high likelihood that the number of affected individuals is much higher than the number known to have the disease [12, 13] . In fact, several studies have reported a very low awareness of and knowledge about glaucoma in the general population [5, 14] , with only 10-50% of people with glaucoma aware that they have the disease [12, 13, [15] [16] [17] . Additionally, the high rate of undiagnosed POAG (92.7%) was shown in a population-based study in Korea [18] . When we estimate the number of patients with glaucoma using the 3.5% glaucoma prevalence reported in a systematic review [2] , the proportion of undetected patients with glaucoma in our study was about 70% (Table 5) . Only patients already diagnosed with glaucoma were included in our analyses. Therefore, the chronic characteristics of glaucoma may be well reflected. Moreover, our underestimated prevalence of glaucoma may have resulted from the high proportion of NTG in Korea. Journal of Ophthalmology Although elevated intraocular pressure (IOP) is the hallmark sign and a well-known risk factor for glaucoma, several population-based studies found that IOP was <22 mmHg in 25-50% of glaucoma patients [19] . In fact, 77% of patients with OAG in Korea have NTG [18] . Unfortunately, NTG cannot be detected through tonometry. Therefore, it is more difficult to detect than OAG with ocular hypertension.
Even though our estimated prevalence of diagnosed glaucoma was lower than in other population-based studies, the features of glaucoma prevalence were similar. In agreement with previous studies [2, 3, 18, 20] , our multivariate analysis revealed a gender-adjusted OR for glaucoma of 1.7 with each decade increase in age. Additionally, glaucoma was more prevalent in males than in females after adjusting for age (OR: 1.1-1.3) . Some controversy remains about whether gender affects glaucoma prevalence, but previous studies conducted in Korea have also shown a higher prevalence in males [6, 20] . In our multivariate analysis model, age had a more significant effect on glaucoma prevalence than gender (Table 3) . Additionally, the fact that OAG and ACG accounted for the highest and second highest proportion of glaucoma cases, respectively, is consistent with other studies [2, 20, 21] . We found that the OAG/ACG ratio was 4.9-7.2 (Table 2) , which is also similar to other studies conducted on East Asian populations [7, 21] .
Both the number of glaucoma cases and the number of glaucoma surgeries showed an increasing trend over time. Interestingly, the proportion of money spent on glaucoma surgeries decreased annually (Figure 2 ). This may have been caused by a progressive increase in antiglaucoma medication usage.
Our study had several imitations. First, people with undiagnosed glaucoma were not included in our estimates of glaucoma prevalence, which may have resulted in an underestimated prevalence. Additionally, national claims data do not always match hospital chart records. It has been shown that national claims data and hospital records only have a 70-80% concordance rate [22] . Second, although data from the national claims database better represents the clinical situation than data from population-based studies, inconsistencies between clinicians in disease diagnostic criteria and practical patterns may have influenced our results, especially for angle closure glaucoma. Finally, we did not assess risk factors for glaucoma (e.g., myopia, elevated IOP, and comorbid conditions), which would require further investigation with additional national claims data.
In conclusion, the prevalence and socioeconomic burden of glaucoma are increasing annually. Nevertheless, based on national claims data, we speculate that many patients with glaucoma remain undiagnosed in Korea. Ways to identify these patients are needed so that the disease can be managed to minimize vision loss in glaucoma patients with a long life expectancy.
